Achieve Life To Advance Cytisinicline Into Phase 3 Study For Vaping Cessation In Q3, 2025

RTTNewsDec 3 10:15 ET

Achieve Life Sciences Announces Outcome of End-of-Phase 2 Meeting With FDA

TipRanksDec 3 08:40 ET

Express News | Achieve Life Sciences Inc - Expects to File Nda for Smoking Cessation in Q2 2025

ReutersDec 3 08:31 ET

Express News | Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting With FDA

ReutersDec 3 08:30 ET

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

Achieve LifeNov 14 08:30 ET

This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

BenzingaNov 14 07:53 ET